Citation:Peeters M, Price TJ, Cervantes A, Sobrero AF, Ducreux M, Hotko Y, et al 2010

From Cancer Guidelines Wiki

Citation


Peeters M, Price TJ, Cervantes A, Sobrero AF, Ducreux M, Hotko Y, et al. Randomized phase III study of panitumumab with fluorouracil, leucovorin, and irinotecan (FOLFIRI) compared with FOLFIRI alone as second-line treatment in patients with metastatic colorectal cancer. J Clin Oncol 2010 Nov 1;28(31):4706-13 Available from: http://www.ncbi.nlm.nih.gov/pubmed/20921462.



Critical appraisals

Critical appraisal linkClinical questionAssigned toStatus
Peeters M, Price TJ, Cervantes A, Sobrero AF, Ducreux M, Hotko Y, et al 2010Optimal molecular profilingpending
Peeters M, Price TJ, Cervantes A, Sobrero AF, Ducreux M, Hotko Y, et al 2010 2Optimal molecular profilingpending

Compare quality appraisals for each clinical question

  • [[Clinical question:Molecular profiling of CRC|
    Invalid title «<span class="smw-format list-format "><span class="smw-row"><span class="smw-field"><span class="smw-value">Clinical question:Molecular profiling of CRC</span></span></span>»
    ]] (compare critical appraisals)
  • [[Clinical question:Molecular profiling of CRC|
    Invalid title «<span class="smw-row"><span class="smw-field"><span class="smw-value">Clinical question:Molecular profiling of CRC</span></span></span></span>»
    ]] (compare critical appraisals)

Cited by

  1. Molecular pathology and biomarkers – implications for systemic therapy
  2. Systemic options for second-line treatment
Retrieved from "https://wiki.cancer.org.au/australiawiki/index.php?title=Citation:Peeters_M,_Price_TJ,_Cervantes_A,_Sobrero_AF,_Ducreux_M,_Hotko_Y,_et_al_2010&oldid=149663"